Biosergen AB
BIOSGN | FN
Overview
Corporate Details
- ISIN(s):
- SE0016013460 (+2 more)
- LEI:
- 549300YD2OGUE7BMP925
- Country:
- Sweden
- Address:
- Fogdevreten 2, 171 65 Solna
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Biosergen AB is a Swedish biotech company focused on developing antifungal treatments. It addresses life-threatening fungal infections resistant to existing therapies.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Merck KGaA | United States of America | 6MK | |
| Metabolic Nordic AB | Sweden | MBOLIC | ||
|
Modus Therapeutics Holding AB | Sweden | MODTX | |
|
Molecure S.A. | Poland | MOC | |
|
M WINKWORTH PLC | United Kingdom | WINK | |
|
Mycodern Spolka Akcyjna | Poland | MCD | |
|
Nanexa AB | Sweden | NANEXA | |
|
Nanobiotix | France | NANO | |
|
Nanoform Finland OYJ | Finland | NANOFH | |
|
NanoGroup S.A. | Poland | NNG |